Search Results - "Diepstra, Karen L."

Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366 by Dubé, Karine, Hosey, Lara, Starr, Kate, Barr, Liz, Evans, David, Hoffman, Erin, Campbell, Danielle M, Simoni, Jane, Sugarman, Jeremy, Sauceda, John, Brown, Brandon, Diepstra, Karen L, Godfrey, Catherine, Kuritzkes, Daniel R, Wohl, David A, Gandhi, Rajesh, Scully, Eileen

“…Women remain underrepresented in HIV research. The AIDS Clinical Trials Group (ACTG) 5366 study was the first HIV cure-related trial conducted exclusively in…”
Get more information

Comprehensive Ryan White Assistance and Human Immunodeficiency Virus Clinical Outcomes: Retention in Care and Viral Suppression in a Medicaid Nonexpansion State by Diepstra, Karen L., Rhodes, Anne G., Bono, Rose S., Patel, Sonam, Yerkes, Lauren E., Kimmel, April D.

“…Background. Knowledge gaps remain about how the Ryan White human immunodeficiency virus (HIV)/AIDS Program (RW) contributes to health outcomes. We examined the…”
Get full text

Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker Study by Diepstra, Karen L, Barr, Liz, Palm, David, Hogg, Evelyn, Mollan, Katie R, Henley, Laney, Stover, Angela M, Simoni, Jane M, Sugarman, Jeremy, Brown, Brandon, Sauceda, John A, Deeks, Steven, Fox, Lawrence, Gandhi, Rajesh T, Smith, Davey, Li, Jonathan Z, Dubé, Karine

“…The AIDS Clinical Trials Group (ACTG) A5345 study included an intensively monitored antiretroviral pause (IMAP), during which a cohort of participants…”
Get more information

Prevalence and Predictors of Provider-Initiated HIV Test Offers Among Heterosexual Persons at Increased Risk for Acquiring HIV Infection — Virginia, 2016 by Diepstra, Karen L., Cunningham, Tina, Rhodes, Anne G., Yerkes, Lauren E., Buyu, Celestine A.

“…Since 2006, CDC has recommended routine, provider-initiated human immunodeficiency virus (HIV) screening (i.e., HIV screening at least once in lifetime) for…”
Get full text

Prevalence and Predictors of Provider-Initiated HIV Test Offers Among Heterosexual Persons at Increased Risk for Acquiring HIV Infection - Virginia, 2016 by Diepstra, Karen L, Cunningham, Tina, Rhodes, Anne G, Yerkes, Lauren E, Buyu, Celestine A

“…CDC recommends routine, provider-initiated HIV screening (i.e., HIV screening at least once in lifetime) for all patients aged 13-64 years in all health care…”
Get full text